Heska Corporation (HSKA) Stock Price & Overview

NASDAQ:HSKAUS42805E3062

Current stock price

119.99 USD
+0.05 (+0.04%)
At close:
119.99 USD
0 (0%)
After Hours:

The current stock price of HSKA is 119.99 USD. Today HSKA is up by 0.04%. In the past month the price increased by 2.45%. In the past year, price increased by 42.46%.

HSKA Key Statistics

52-Week Range57.8321 - 120.03
Current HSKA stock price positioned within its 52-week range.
1-Month Range115.42 - 120.03
Current HSKA stock price positioned within its 1-month range.
Market Cap
1.31B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.93
Dividend Yield
N/A

HSKA Stock Performance

Today
+0.04%
1 Week
+0.08%
1 Month
+2.45%
3 Months
+35.58%
Longer-term
6 Months +91.34%
1 Year +42.46%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

HSKA Stock Chart

Heska Corporation / HSKA Daily stock chart

HSKA Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to HSKA. When comparing the yearly performance of all stocks, HSKA is one of the better performing stocks in the market, outperforming 93.8% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

HSKA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to HSKA. While HSKA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HSKA Earnings

Next Earnings DateAug 7, 2023
Last Earnings DateMay 5, 2023
PeriodQ1 / 2023
EPS Reported-$0.97
Revenue Reported
EPS Surprise -88.31%
Revenue Surprise -4.99%

HSKA Forecast & Estimates

10 analysts have analysed HSKA and the average price target is 132.6 USD. This implies a price increase of 10.51% is expected in the next year compared to the current price of 119.99.

For the next year, analysts expect an EPS growth of 55.25% and a revenue growth 9.92% for HSKA


Analysts
Analysts78
Price Target132.6 (10.51%)
EPS Next Y55.25%
Revenue Next Year9.92%

HSKA Groups

Sector & Classification

Index Membership

HSKA Financial Highlights

Over the last trailing twelve months HSKA reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS decreased by -51.97% compared to the year before.


Income Statements
Revenue(TTM)254.89M
Net Income(TTM)-20.03M
Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0.23
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%-3.73%
EPS 1Y (TTM)-51.97%
Revenue 1Y (TTM)-1.22%

HSKA Ownership

Ownership
Inst Owners0.01%
Shares10.91M
Float10.05M
Ins Owners3.86%
Short Float %N/A
Short RatioN/A

About HSKA

Company Profile

HSKA logo image Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 808 full-time employees. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The firm has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.

Company Info

IPO: 1997-07-10

Heska Corporation

3760 Rocky Mountain Ave

Loveland COLORADO 80538 US

CEO: Kevin S. Wilson

Employees: 808

HSKA Company Website

Phone: 19704937272.0

Heska Corporation / HSKA FAQ

Can you describe the business of Heska Corporation?

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. The company is headquartered in Loveland, Colorado and currently employs 808 full-time employees. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The firm has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.


What is the stock price of Heska Corporation today?

The current stock price of HSKA is 119.99 USD. The price increased by 0.04% in the last trading session.


Does Heska Corporation pay dividends?

HSKA does not pay a dividend.


What is the ChartMill technical and fundamental rating of HSKA stock?

HSKA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Which stock exchange lists HSKA stock?

HSKA stock is listed on the Nasdaq exchange.


What is the next earnings date for HSKA stock?

Heska Corporation (HSKA) will report earnings on 2023-08-07, before the market open.